Expertise in
10
conditions

Chigusa Morizane

Tokyo, JP 
Expertise in
10
conditions
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Chigusa Morizane practices in Tokyo, Japan. Morizane is highly rated in 10 conditions, according to our data. Their top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Pancreatic Islet Cell Tumor, Stent Placement, and Pancreaticoduodenectomy.

Their clinical research consists of co-authoring 208 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

Tokyo, Japan
Other Locations
Chuo, 1040045, Japan
Tsukiji, Japan
Chuo, Japan
Japan
Sawara, 8140001, Japan
Kashiwa, 2778577, Japan
Tsukiji, 1040045, Japan
Shizuoka, 4118777, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) as First-line Treatment of Biliary Tract Cancer
A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) as First-line Treatment of Biliary Tract Cancer
Enrollment Status: Terminated
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drugs: Bintrafusp Alfa, Gemcitabine, Cisplatin
Study Phase: Phase 2/Phase 3

208 Total Publications

Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study.
Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study.
Journal: JCO precision oncology
Published: April 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Morizane's expertise for a condition
ConditionClose
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile